V

Voyager Therapeutics
D

VYGR

3.20000
USD
0.00
(0.00%)
مغلق
حجم التداول
7,681
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
177,076,627
أصول ذات صلة
ALNY
ALNY
-4.39
(-1.33%)
325.26 USD
BMRN
BMRN
0.560
(0.98%)
57.750 USD
C
CRSP
0.455
(0.88%)
52.120 USD
E
EDIT
0.02000
(0.78%)
2.57000 USD
I
IONS
-0.450
(-1.03%)
43.190 USD
N
NTLA
-0.020
(-0.19%)
10.710 USD
REGN
REGN
-0.69
(-0.13%)
546.88 USD
S
SGMO
0.00200
(0.38%)
0.53200 USD
المزيد
الأخبار المقالات

العنوان: Voyager Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.